Longitudinal changes in mNIS+7 are associated with changes in ambulatory status in hereditary transthyretin-mediated amyloidosis

被引：0
|
作者：
Coelho, Teresa [1 ]
Suhr, Ole [2 ]
Quan, Dianna [3 ]
Brannagan, Thomas [4 ]
Gollob, Jared [5 ]
Goyal, Sunita [5 ]
Altincatal, Arman [6 ]
Agarwal, Sonalee [5 ]
Lin, Hollis [5 ]
Adams, David [7 ]
机构：
[1] Hosp Santo Antonio, Porto, Portugal
[2] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden
[3] Univ Colorado, Aurora, CO USA
[4] Columbia Univ, New York, NY USA
[5] Alnylam Pharmaceut, Cambridge, MA USA
[6] Evidera Inc, Waltham, MA USA
[7] CHU Bicetre, AP HP, Natl Reference Ctr FAP NNERF, INSERM,U1195, Le Kremlin Bicetre, France
来源：
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM | 2018年 / 23卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：354 / 355
页数：2
相关论文
共 50 条
  • [1] Responsiveness of mNIS+7 components in inotersen treatment of hereditary transthyretin amyloidosis polyneuropathy
    Dyck, P. J. B.
    Kincaid, J. C.
    Wiesman, J. F.
    Polydefkis, M.
    Litchy, W. J.
    Mauermann, M. L.
    Ackermann, E. J.
    Guthrie, S.
    Pollock, M.
    Jung, S. W.
    Baker, B. F.
    Dyck, P. J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 714 - 714
  • [2] Patisiran in hereditary transthyretin-mediated amyloidosis
    Luigetti, Marco
    Servidei, Serenella
    LANCET NEUROLOGY, 2021, 20 (01): : 21 - 23
  • [3] mNIS+7and lower limb function in inotersen treatment ofhereditary transthyretin-mediated amyloidosis
    Dyck, P. James B.
    Kincaid, John C.
    Wiesman, Janice F.
    Polydefkis, Michael
    Litchy, William J.
    Mauermann, Michelle L.
    Ackermann, Elizabeth J.
    Guthrie, Spencer
    Pollock, Michael
    Jung, Shiangtung W.
    Baker, Brenda F.
    Dyck, Peter J.
    MUSCLE & NERVE, 2020, 62 (04) : 502 - 508
  • [4] Patisiran for the treatment of hereditary transthyretin-mediated amyloidosis
    Yang, Junyi
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (02) : 95 - 99
  • [5] Vutrisiran: A Review in Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis
    Nie, Tina
    Heo, Young-A
    Shirley, Matt
    DRUGS, 2023, 83 (15) : 1425 - 1432
  • [6] NEUROPATHY IMPAIRMENT AND NUTRITIONAL STATUS WITH EPLONTERSEN IN PATIENTS WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS
    Conceicao, Isabel
    Wixner, Jonas
    Berk, John
    Adams, David
    Polydefkis, Michael
    Attarian, Shahram
    Gillmore, Julian
    Dyck, P. James
    Coelho, Teresa
    Chen, Jersey
    Hardy, Elise
    Kwoh, Jesse
    Natman, Jonatan
    Cruz, Marcia Waddington
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2024, 29 : S138 - S138
  • [7] Neuropathy impairment and nutritional status with eplontersen in patients with hereditary transthyretin-mediated amyloidosis
    Wixner, Jonas
    Conceicao, Isabel
    Berk, John
    Adams, David
    Polydefkis, Michael
    Shahram, Attarian
    Gillmore, Julian D.
    Dyck, P. James B.
    Coelho, Teresa
    Chen, Jersey
    Hardy, Elise
    Kwoh, Jesse
    Natman, Jonatan
    Cruz, Marcia Waddington
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2024, 31 : S68 - S68
  • [8] Vutrisiran: A Review in Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis
    Tina Nie
    Young-A Heo
    Matt Shirley
    Drugs, 2023, 83 : 1425 - 1432
  • [9] Neurofilament Light Chain as a Biomarker of Hereditary Transthyretin-Mediated Amyloidosis
    Ticau, Simina
    Sridharan, Gautham, V
    Tsour, Shira
    Cantley, William L.
    Chan, Amy
    Gilbert, Jason A.
    Erbe, David
    Aldinc, Emre
    Reilly, Mary M.
    Adams, David
    Polydefkis, Michael
    Fitzgerald, Kevin
    Vaishnaw, Akshay
    Nioi, Paul
    NEUROLOGY, 2021, 96 (03) : E412 - E422
  • [10] Diagnostic delay in patients with sporadic hereditary transthyretin-mediated amyloidosis
    Antunes, Bernardo
    Conceicao, Isabel
    de Campos, Catarina Falcao
    de Carvalho, Mamede
    NEUROLOGICAL SCIENCES, 2025, 46 (02) : 929 - 934
12345